Multi-Phasic CECT Peritumoral Radiomics Predict Treatment Response to Bevacizumab-Based Chemotherapy in RAS-Mutated Colorectal Liver Metastases.

This was followed by features from the DeltaP phase, where all three predictors were also highly significant with a uniform FDR of 0.009 (GLRLM_Run Length Non-Uniformity, GLDM_Dependence Non-Uniformity, GLDM_Small Dependence Emphasis), yielding AUC between 0.713 and 0.738.

also in 132,142 other papers